📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Detraxi

1.1 - Company Overview

Detraxi Logo

Detraxi

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of proprietary biotechnology solutions addressing blood and organ shortages, including alternatives to whole or derived blood products aimed at eliminating the need for donations; technologies to preserve and regenerate organs outside the body to extend transplant viability; regenerative medicine to engineer organs and reduce reliance on donated tissues; and enhanced diagnostics to better preserve samples and improve test accuracy.

Products and services

  • Ending The Organ Donation Crisis: Detraxi architects an outside-the-body technology that preserves and regenerates organs, extending viability and availability for transplantation to mitigate the organ donation crisis
  • Ending The Global Blood Shortage: Detraxi engineers a biotechnology-based product that eliminates reliance on blood donations by supplying an alternative to whole or derived blood products, targeting the global blood shortage
  • Regenerative Medicine: Detraxi advances proprietary regenerative medicine focused on engineering and regenerating organs outside the body to treat diseases and reduce reliance on donated tissues

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Detraxi

Greyson Logo

Greyson

HQ: United States Website
  • Description: Provider of health and beauty aid products, engaging in their research, development, and marketing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Greyson company profile →
Sarissa Biomedical Logo

Sarissa Biomedical

HQ: United Kingdom Website
  • Description: Provider of minimally invasive microelectrode electrochemical biosensors that detect purines and other neurochemicals, such as serotonin and dopamine, in blood to aid diagnosis and monitoring of neurological disorders. Solutions offer exquisite sensitivity, broad linear range, rapid measurements, and high accuracy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sarissa Biomedical company profile →
Standard BioTools Logo

Standard BioTools

HQ: United States Website
  • Description: Provider of microfluidic-based chips and instrumentation for biological research as a biotech tools company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Standard BioTools company profile →
Neothetics Logo

Neothetics

HQ: United States Website
  • Description: Provider of clinical-stage specialty pharmaceutical therapeutics for the aesthetic market.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Neothetics company profile →
Magnolia Medical Logo

Magnolia Medical

HQ: United States Website
  • Description: Provider of blood culture contamination reduction solutions, including Steripath Initial Specimen Diversion Device and Steripath Micro to divert and sequester initial blood draws, the Mission Control educational platform offering best-practice collection training, and a clinical performance guarantee of at least 50% contamination reduction or money back.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Magnolia Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Detraxi

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Detraxi

2.2 - Growth funds investing in similar companies to Detraxi

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Detraxi

4.2 - Public trading comparable groups for Detraxi

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Detraxi

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Detraxi

What does Detraxi do?

Detraxi is a provider of proprietary biotechnology solutions addressing blood and organ shortages, including alternatives to whole or derived blood products aimed at eliminating the need for donations; technologies to preserve and regenerate organs outside the body to extend transplant viability; regenerative medicine to engineer organs and reduce reliance on donated tissues; and enhanced diagnostics to better preserve samples and improve test accuracy.

Who are Detraxi's competitors?

Detraxi's competitors and similar companies include Greyson, Sarissa Biomedical, Standard BioTools, Neothetics, and Magnolia Medical.

Where is Detraxi headquartered?

Detraxi is headquartered in United States.

How many employees does Detraxi have?

Detraxi has 1,000 employees 🔒.

When was Detraxi founded?

Detraxi was founded in 2010 🔒.

What sector and industry vertical is Detraxi in?

Detraxi is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Detraxi

Who are the top strategic acquirers in Detraxi's sector and industry

Top strategic M&A buyers and acquirers in Detraxi's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Detraxi?

Top strategic M&A buyers groups and sectors for Detraxi include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Detraxi's sector and industry vertical

Which are the top PE firms investing in Detraxi's sector and industry vertical?

Top PE firms investing in Detraxi's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Detraxi's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Detraxi's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Detraxi's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Detraxi include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Detraxi's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Detraxi?

The key public trading comparables and valuation benchmarks for Detraxi include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Detraxi for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Detraxi with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Detraxi's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Detraxi with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Detraxi's' sector and industry vertical?

Access recent funding rounds and capital raises in Detraxi's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Detraxi

Launch login modal Launch register modal